Aquatic Capital Management LLC Fate Therapeutics Inc Transaction History

Aquatic Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $820,352 - $1.98 Million	83,200 Added 2521.21%	86,500 $872,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $69,432 - $118,998	3,300 New	3,300 $74,000
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $10,668 - $25,434	-600 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $26,703 - $54,252	-900 Reduced 60.0%	600 $23,000
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $71,760 - $96,510	1,500 New	1,500 $88,000

167

101M

41.3K

15.9K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $88.3M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.